CYMABAY THERAPEUTICS, INC.
7999 Gateway Blvd., Suite 130
Newark, CA 94560
(510) 293-8800
June 27, 2017
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Christine Westbrook
| RE: | CymaBay Therapeutics, Inc. |
Registration Statement on Form S-3
File No. 333-217889
Ladies and Gentlemen:
CymaBay Therapeutics, Inc. hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on June 29, 2017, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.
Very truly yours,
CymaBay Therapeutics, Inc. | ||
| By: | /s/ Sujal Shah | |
Sujal Shah Interim President and Chief Executive Officer | ||
